Condition

Wolff-Parkinson-White Syndrome

ClinicalTrials.gov condition label

Clinical trials8
Recruiting2
Common interventions13
Lead sponsors shown8

Clinical trials

8 shown
ATR 1072 in Participants With PRKAG2 SyndromeNCT07738107 · 2026-09-14
RECRUITING
AI-Based Differential Diagnosis and Localization of Tachycardia Using ECG: Multicenter Registry (EP-AI ASSIST)NCT07859020 · 2023-12-01
RECRUITING
Physical Activity in Children With Wolff-Parkinson-White SyndromeNCT06349109 · 2024-03-01
COMPLETED
Accessory Pathway Antegrade Effective Refractory Period Among WPW Patients: the Risk in Relation to the LocationNCT04106622 · 2020-03-01
UNKNOWN
Stress ECG Test for the Evaluation of the Risk of Sudden Cardiac Death in a Paediatric Cohort With WPW PatternNCT03207373 · 2017-04-13
TERMINATED
Risk Assessment in Patients With Symptomatic- and Asymptomatic PreexcitationNCT03301935 · 2016-12-01
COMPLETED
Wolff-Parkinson-White Syndrome Anterograde Refractory Period of Accessory DuctNCT00873470 · 2009-02-01
TERMINATED
Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECGNCT00251121 · 2005-11-01
COMPLETED

Common interventions

AI-based ECG Diagnostic and Localization AlgorithmDIAGNOSTIC_TEST1Arterial Stiffness MeasurementOTHER1ATR 1072DRUG1Atrial pacingOTHER1Atrial-Ventricular Strain AnalysisOTHER1Cardiopulmonary exercise testOTHER1electrophysiological studyPROCEDURE1Electrophysiology testing and exercise stress testingPROCEDURE1esophagal stimulationPROCEDURE1Mini-invasive electrophysiological studyOTHER1Physical Activity Barriers AssesmentOTHER1Physical Activity LevelOTHER1Stress test (ECG)DIAGNOSTIC_TEST1

Trial status mix

COMPLETED3
RECRUITING2
TERMINATED2
UNKNOWN1

Phase mix

NA3
PHASE11
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.